Estimating Minimally Important Differences for the Worst Pain Rating of the Brief Pain Inventory–Short Form
SD Mathias, RD Crosby, Y Qian, Q Jiang, R Dansey, K Chung
20110201
2011 Mar 1
J Support Oncol
Yes
Estimating Minimally Important Differences for the Worst Pain Rating of the Brief Pain Inventory–Short Form
J Support Oncol. 2011 Mar 1;9(2):72-78, SD Mathias, RD Crosby, Y Qian, Q Jiang, R Dansey, K Chung
Abstract
The Brief Pain Inventory–Short Form (BPI-SF) is widely used for assessing pain in clinical and research studies. The worst pain rating is often the primary outcome of interest; yet, no published data are available on its minimally important difference (MID). Breast cancer patients with bone metastases enrolled in a randomized, double-blind, phase III study comparing denosumab with zoledronic acid for preventing skeletal related events and completed the BPI-SF, FACT-B, and EQ-5D at baseline, week...
